{
    "clinical_study": {
        "@rank": "35172", 
        "arm_group": {
            "arm_group_label": "Capsule endoscopy", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "This study is designed to evaluate the responsiveness of VCE in the assessment of mucosal\n      inflammation after 6 months of treatment with either an Immunomodulator (IMM) and\\or\n      biological drug."
        }, 
        "brief_title": "Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects Receiving an Immunomodulator (IMM) and\\or a Biological Treatment", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Active Crohn Disease With Terminal Ileal Disease", 
        "condition_browse": {
            "mesh_term": [
                "Crohn Disease", 
                "Ileal Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, multi-center (up to 15 sites) study which aims to assess the ability\n      of VCE (Video capsule endoscopy) to detect change in the severity of the small bowel mucosal\n      disease activity in CD subjects after 6 months of treatment with either an Immunomodulator\n      (IMM) and\\ or biological drug.\n\n      Up to 75 subjects will participate in this study. An interim analysis will be done after\n      study completion with 20 subjects. All subjects to be enrolled in this study will be\n      pediatric and\\or adult subjects with Crohn's disease who will be treated with an\n      Immunomodulator and/or a biological treatment based on standard clinical evaluation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject ages 2-75 years, inclusive\n\n          2. Subjects with a diagnosis of known Crohn disease\n\n          3. Referred to standard-of-care ileocolonoscopy (up to 4 weeks before the CE procedure)\n\n          4. Subjects with a plan to be treated with an immunomodulator and/or a biologic\n             medication following the ileocolonoscopy exam including any of the following:\n\n               1. modification of dose or frequency of current therapy\n\n               2. addition of a new therapy\n\n               3. change to a different therapy within-class or out-of-class\n\n          5. Subject has active terminal ileal disease proven by capsule or ileocolonoscopy\n             procedure (note that subjects with colonic disease or other disease locations can be\n             enrolled as long as they also have terminal ileal disease)\n\n          6. Proven patency by the Agile capsule or another approach deemed clinically acceptable\n             by the investigator, e.g. CT enterography, MRE, performed within the 90 days prior to\n             enrollment.\n\n          7. Subject or parent agrees to sign consent form\n\n        Exclusion Criteria:\n\n        The presence of any of the following will exclude a subject from study enrollment:\n\n          1. Subjects with change in IBD drug therapy between the baseline ileocolonoscopy and VCE\n\n          2. Subjects with a history of prior ileocecectomy, Ileal Pouch-Anal Anastomosis (IPAA)\n             and J pouch or an ostomy\n\n          3. Stricture seen on radiological exam.\n\n          4. Indeterminate Colitis\n\n          5. Ulcerative Colitis\n\n          6. Antibiotic Associated Colitis\n\n          7. Known history of intestinal obstruction or current obstructive symptoms, such as\n             severe abdominal pain with accompanying nausea or vomiting, based on investigator\n             judgment.\n\n          8. Non-steroidal anti-inflammatory drugs including aspirin (twice weekly or more), not\n             including aspirin up to 81mg daily, during the 4 weeks preceding enrollment\n\n          9. Suspected GI stricture, followed by PillCam\u00ae Patency study or other imaging study\n             that could not prove patency of the GI tract.\n\n         10. Subject is expected to undergo MRI examination within 7 days after ingestion of the\n             capsule.\n\n         11. Subjects with known or suspected delayed gastric emptying\n\n         12. Subjects with known or suspected delayed Small bowel motility\n\n         13. Subject has any allergy or other known contraindication to the medications used in\n             the study.\n\n         14. Women who are either pregnant or nursing at the time of screening, or are of\n             child-bearing potential and do not agree to practice medically acceptable methods of\n             contraception.\n\n         15. Unwillingness to use a medically accepted method of contraception throughout duration\n             of study\n\n         16. Concurrent participation in another clinical trial using any investigational drug or\n             device.\n\n         17. Subject has cardiac pacemaker or other implanted electromedical devices\n\n         18. Subject suffers from a life threatening condition.\n\n         19. Subject with a history or clinical evidence of renal disease and/or previous\n             clinically significant laboratory abnormalities of renal function parameters.\n\n         20. Subject suffers from any condition, such as swallowing problems, which precludes\n             compliance with study and/or device instructions."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01942720", 
            "org_study_id": "MA-209"
        }, 
        "intervention": {
            "arm_group_label": "Capsule endoscopy", 
            "intervention_name": "Capsule endoscopy and Ileocolonoscopy tests", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Adjuvants, Immunologic", 
                "Immunologic Factors"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 16, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Grant Erickson"
                }, 
                "facility": {
                    "address": {
                        "city": "Scottsdale, AZ", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "Mayo Clinic"
                }, 
                "investigator": {
                    "last_name": "Shabbana Pasha, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Cynthia Walsh"
                }, 
                "facility": {
                    "address": {
                        "city": "LA", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Cedars Sinai Medical Center"
                }, 
                "investigator": {
                    "last_name": "Gil Melmed, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Laura Walter"
                }, 
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Borland-Groover Clinic"
                }, 
                "investigator": {
                    "last_name": "Mark Fleisher, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "kara Fitch"
                }, 
                "facility": {
                    "address": {
                        "city": "Winter Park", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Shafran Gastroenterology Center"
                }, 
                "investigator": {
                    "last_name": "Irra Shafran, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Angela Stallworth"
                }, 
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "Children's Center for Digestive Healthcare"
                }, 
                "investigator": {
                    "last_name": "Stan Cohen", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Rose Arrieta"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "The University of Chicago"
                }, 
                "investigator": {
                    "last_name": "Sakuraba Atsushi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gewn Coock"
                }, 
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana"
                    }, 
                    "name": "Indiana Unveresity Hospital"
                }, 
                "investigator": {
                    "last_name": "Debra Helper, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jene Formaro"
                }, 
                "facility": {
                    "address": {
                        "city": "Clive", 
                        "country": "United States", 
                        "state": "Iowa"
                    }, 
                    "name": "Iowa Digestive Disease Center"
                }, 
                "investigator": {
                    "last_name": "Bernard Leman, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Guruprasad Jambaulikar"
                }, 
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "University of Maryland Medical Center"
                }, 
                "investigator": {
                    "last_name": "Gahazi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Cindy coates"
                }, 
                "facility": {
                    "address": {
                        "city": "Chevy Chase", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "Metropolitan Gastroenterology Group"
                }, 
                "investigator": {
                    "last_name": "Robert Hardi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Joe Palmer"
                }, 
                "facility": {
                    "address": {
                        "city": "Michigan", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Digestive Health Center of Michigan"
                }, 
                "investigator": {
                    "last_name": "Robert Fogel, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Annette Langseder"
                }, 
                "facility": {
                    "address": {
                        "city": "Morristown", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Atlantic Health System Morristown Memorial Pediatric GE"
                }, 
                "investigator": {
                    "last_name": "Joel Rosh, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Paris Laliberte"
                }, 
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "UNC Chapel Hill"
                }, 
                "investigator": {
                    "last_name": "Kim Isaacs, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "JoAnne Tiamzon"
                }, 
                "facility": {
                    "address": {
                        "city": "Chesapeak", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "Gastroenterology Associates of Tidewater"
                }, 
                "investigator": {
                    "last_name": "Malik Pramod, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects Receiving an Immunomodulator (IMM) and\\or a Biological Treatment", 
        "overall_contact": {
            "last_name": "Moran Weisshof", 
            "phone": "+972-4-9907759"
        }, 
        "overall_official": [
            {
                "affiliation": "Mayo Clinic", 
                "last_name": "Jonathan Leighton, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Cyder Cinai LA", 
                "last_name": "Gil Melmed, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To correlate the mucosal change in VCE mucosal score (Lewis score and CECDEIS) with change in Physician Global Assessment of CD activity 6 months after Immunomodulator (IMM) and\\or biological treatment", 
            "measure": "mucosal change in VCE mucosal scores and PGA", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01942720"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluate the correlation between SES CD score and capsule scoring indexes (Lewis and CECDEIS) in the TI at baseline.", 
                "measure": "correlation between SES CD score and capsule scoring indexes", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Evaluate the correlation between the change in SES CD score and the change in capsule scoring indexes (Lewis and CECDEIS) in the TI after 6 months (for the subset of subjects who have IC at 6 months)", 
                "measure": "correlation between the change in SES CD score and the change in capsule scoring indexes- in terminal ileum", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Evaluate the entire SB CE Scores (Lewis & CECDEIS) change as compared to the change at TI in CE Scores (Lewis & CECDEIS)", 
                "measure": "Evaluate the entire SB CE Scores", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "To assess safety related to capsule retention and other adverse events", 
                "measure": "safety related to capsule", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Given Imaging Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Given Imaging Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}